Skip to content
Open access

miR-146b-5p Suppresses Btg2 to Promote Fibroblast Proliferation and Is Associated with Prrx2 and Myh10

Sep 2026 · Biomolecules · Vol 16, pp. 1407 · 0 citations · 37 references

TL;DR

Results showed that time-series clustering and H&E staining confirmed successful modeling of the transition from acute inflammation to chronic fibrosis induced by SiO2, and provided new experimental evidence for the molecular mechanisms of silica-induced pulmonary fibrosis in a mouse model.

Abstract

Pulmonary fibrosis is a chronic progressive lung disease characterized by abnormal proliferation and activation of fibroblasts. However, the regulatory mechanisms of miRNAs and their target genes on fibroblast proliferation during silicosis (silica-induced pulmonary fibrosis) remain incompletely understood. A mouse silicosis model was established by dynamic dust inhalation, and lung tissues were collected at 7, 14, 28, and 56 days after dust exposure, followed by multi-time-point miRNA sequencing and transcriptome sequencing. Using integrated omics, bioinformatics analysis, and molecular interaction validation, the key miRNAs and their target genes regulating fibroblast proliferation were screened and verified. The results showed that time-series clustering and H&E staining confirmed successful modeling of the transition from acute inflammation to chronic fibrosis induced by SiO2. Differentially expressed miR-146b-5p during SiO2 stress may affect the cell cycle of fibroblasts by regulating Btg2. Mechanistically, IP-MS combined with Co-IP identified interactions between Btg2 and Prrx2 or Myh10, suggesting their potential involvement in this regulatory process. These findings provide new experimental evidence for the molecular mechanisms of silica-induced pulmonary fibrosis in a mouse model, and may offer insights for understanding the pathogenesis of human silicosis.

Read PDF

Similar papers

Oct 2026

miR-885-5p regulates fibrogenic phenotypes in TGF-β1-treated LX-2 cells via targeting NR5A2, with clinical association with MAFLD.

BACKGROUND Metabolic-associated fatty liver disease (MAFLD) is a common chronic liver disease worldwide, with liver fibrosis serving as a major determinant of poor prognosis. While miR-885-5p shows dysregulated expression in numerous metabolic and liver disorders, its function in MAFLD has yet to be fully elucidated. T...

Zi-Hui Yu, Rong Zhou, Shun-Yong He · 0 citations
Open access Aug 2026

E2F1-Activated lncRNA FTX Promotes Asthma Progression via Regulating the SRSF1/RBPJ Axis

Purpose Long non-coding RNA five prime to Xist (FTX) is considered a regulator for asthma. Therefore, we aimed to explore its more roles and molecular mechanisms in asthma process. Methods Serum samples from controls and asthmatics were collected. Asthma mouse models were induced with ovalbumin (OVA), and cell models w...

Yu-Ting Lai, Guo-Qing Qiu, Na Li et al. · 0 citations
Open access Sep 2026

circHIPK3 promotes pro-fibrotic epithelial reprogramming via the miR-29a-3p/SPARC axis with associated enhancement of TGF-β/SMAD signaling

Background Idiopathic pulmonary fibrosis (IPF) is fatal with limited treatments. circHIPK3 is upregulated in fibrotic lungs, but its role in lung epithelial cells and connection to TGF-β/SMAD signaling are unclear. Methods We used TGF-β1-stimulated lung epithelial cells (A549, BEAS-2B) and a bleomycin-induced mouse mod...

Ying Zhou, Yi-Xin Huang, Jiang-Po Ma et al. · 0 citations
Open access Sep 2026

Exosomal miR-145-5p inhibits papillary thyroid cancer by targeting TPM3 and inactivating the PI3K-Akt pathway

Within the present study, the objective was to investigate the effects of exosomal miR-145-5p on the proliferation, migration and invasion of papillary thyroid cancer (PTC) cells, and explore the molecular mechanism involved. Bioinformatics analyses based on numerous public databases were conducted to profile the expre...

Yun-Feng Weng, Xian-Jiao Cao, Wen-Yan Song et al. · 0 citations
Oct 2026

PBK drives pulmonary fibrosis via activating p53/ACVR1C/Smad-mediated epithelial-mesenchymal transition.

Pulmonary fibrosis (PF) is a progressive and fatal interstitial lung disease with limited therapeutic options. PDZ-binding kinase (PBK), also known as T-cell-originated protein kinase activated by lymphokines (TOPK), is implicated in cancer progression and inflammation, yet its role in fibrosis remains unexplored. This...

T. Ruan, Yu Zhen, Bei-Lei Wang et al. · 0 citations
Open access Sep 2026

The miR105/767 cluster as a coordinator of apoptosis and PD-L1 expression in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality, largely due to late diagnosis, molecular diversity, and frequent development of treatment resistance. MicroRNAs (miRNAs) play critical roles in NSCLC initiation, progression, and treatment resistance. Previous studies have ide...

Maryam Abdipourbozorgbaghi, R. Radpour, S. Haefliger · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.